"10.1371_journal.pone.0102231","plos one","2014-07-22T00:00:00Z","Linda L Kusner; Michael J Ciesielski; Alexander Marx; Henry J Kaminski; Robert A Fenstermaker","Department of Pharmacology and Physiology, George Washington University, Washington, District of Columbia, United States of America; Department of Neurology, George Washington University, Washington, District of Columbia, United States of America; Department of Neurosurgery, Roswell Park Cancer Institute, Buffalo, New York, United States of America; Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York, United States of America; Institute of Pathology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany","Conceived and designed the experiments: LLK MJC AM HJK RAF. Performed the experiments: LLK MJC AM. Analyzed the data: LLK MJC AM HJK RAF. Contributed reagents/materials/analysis tools: MJC AM HJK RAF. Wrote the paper: LLK HJK RAF.","The authors acknowledge that the authors Michael Ciesielski and Robert Fenstermaker have a conflict of interest based on this manuscript. They hold the patent to SVN53-67/M57-KLH, the vaccine used in the study. They are co-founders of MimiVax, LLC which was developed with the purpose of commercializing the SVN53-67/M57-KLH. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","07","Linda L Kusner","LLK",5,TRUE,5,3,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
